{"id":6970,"date":"2023-06-14T02:20:49","date_gmt":"2023-06-14T02:20:49","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6970"},"modified":"2023-08-29T18:01:22","modified_gmt":"2023-08-29T18:01:22","slug":"inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6970","title":{"rendered":"InhaleRx\u5b8c\u6210\u75bc\u75db\u6cbb\u7597\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c"},"content":{"rendered":"<p>\u603b\u90e8\u4f4d\u4e8e\u58a8\u5c14\u672c\u7684\u533b\u7597\u4fdd\u5065\u516c\u53f8InhaleRx (ASX: IRX)\u7ee7\u7eed\u786e\u8ba4\u5176\u5438\u5165\u836f\u7269\u75bc\u75db\u836f\u7269\u7cfb\u7edf\u7684\u6f5c\u529b\uff0c\u5b8c\u6210\u4e86\u4e00\u7ec4\u521d\u6b65\u8bd5\u9a8c\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u5df2\u7ecf\u8bc1\u5b9e\uff0c\u5176IRX211\u7cfb\u7edf\u7684\u5b89\u5168\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u7814\u7a76\u5df2\u7ecf\u6210\u529f\u5730\u8fdb\u884c\u4e86\u56db\u7ec4\u961f\u5217\u4e2d\u7684\u7b2c\u4e00\u7ec4i\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>IRX211\u662f\u4e00\u79cd\u7531\u5927\u9ebb\u7d20\u884d\u751f\u7684\u836f\u7269dronabinol (THC\u4e3a\u57fa\u7840)\uff0c\u901a\u8fc7\u5438\u5165\u4ee5\u56fa\u5b9a\u5242\u91cf\u7ed9\u836f\uff0c\u4ee5\u89e3\u51b3\u7a81\u7834\u6027\u6216\u6025\u6027\u75bc\u75db\u7684\u75c7\u72b6\u3002<\/p>\n<p>\u76ee\u524d\uff0cInhaleRx\u6b63\u5728\u6d4b\u8bd5\u9488\u5bf9\u7a81\u7834\u6027\u75bc\u75db\u6307\u5f81\u76f8\u5173\u75c7\u72b6\u7684\u836f\u7269\u88c5\u7f6e\u7ec4\u5408\u4ea7\u54c1\uff0c\u5305\u62ec\u590d\u6742\u7684\u5c40\u90e8\u75bc\u75db\u7efc\u5408\u5f81\u548c\u5176\u4ed6\u6025\u6027\u75bc\u75db\u6307\u5f81\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u7684\u8bd5\u9a8c\u9879\u76ee\u662f\u9996\u6279\u6d89\u53ca\u5438\u5165\u5927\u9ebb\u7d20\u836f\u7269\u6cbb\u7597\u75bc\u75db\u548c\u7126\u8651\u76f8\u5173\u75be\u75c5\u7684\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u4e00\u3002<\/p>\n<h2>\u6570\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a<\/h2>\n<p>\u6162\u6027\u75bc\u75db\u5e02\u573a\u9884\u8ba1\u5c06\u4ece2023\u5e74\u7684731.4\u4ebf\u7f8e\u5143 (1070\u4ebf\u6fb3\u5143) \u6269\u5927\u52302033\u5e74\u76841425.3\u4ebf\u7f8e\u5143 (2105\u4ebf\u6fb3\u5143)\uff0c\u5728\u9884\u6d4b\u671f\u5185\u4ee56.9%\u7684\u590d\u5408\u5e74\u589e\u957f\u7387 (CAGR) \u589e\u957f\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u5728\u63a8\u52a8\u5176\u72ec\u7279\u4ea7\u54c1\u5546\u4e1a\u5316\u65b9\u9762\u5df2\u7ecf\u53d6\u5f97\u4e86\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0c\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40 (FDA) \u8fdb\u884c\u4e86\u521d\u6b65\u8ba8\u8bba\uff0c\u5e76\u786e\u5b9a\u4e86\u83b7\u5f97\u76d1\u7ba1\u6279\u51c6\u7684\u9014\u5f84\u3002<\/p>\n<h2>\u7b2c\u4e00\u961f\u5217\u6218\u5f79<\/h2>\n<p>\u7b2c\u4e00\u7ec41\u671f\u8bd5\u9a8c\u7684\u7279\u70b9\u662f\u7ed9\u836f8\u540d\u53c2\u4e0e\u8005\u3002<\/p>\n<p>InhaleRx\u63d0\u524d\u6210\u529f\u5b8c\u6210\u4e86\u961f\u5217\u7814\u7a76\uff0c\u5e76\u5df2\u5f00\u59cb\u7b5b\u9009\u6f5c\u5728\u7684\u7b2c\u4e8c\u961f\u5217\u53c2\u4e0e\u8005\u3002<\/p>\n<p>\u5b8c\u6574\u7684IRX211\u5b89\u5168\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u8bd5\u9a8c\u5c06\u6d89\u53ca4\u4e2a\u961f\u5217\uff0c\u6bcf\u7ec48\u540d\u53c2\u4e0e\u8005\uff0c\u603b\u517132\u540d\u53c2\u4e0e\u8005\uff0c\u4ed6\u4eec\u5c06\u5728\u53cc\u76f2\u3001\u968f\u673a\u3001\u5b89\u6170\u5242\u5bf9\u7167\u3001\u5355\u6b21\u9012\u589e\u5242\u91cf\u7814\u7a76\u4e2d\u63a5\u53d7IRX211\u6216\u5b89\u6170\u5242\u6cbb\u7597\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98Darryl Davies\u8868\u793a\uff0c\u8fd9\u4e9b\u8bd5\u9a8c\u7684\u7ed3\u679c\u65e8\u5728\u8bc4\u4f30IRX211\u7684\u5355\u6b21\u9012\u589e\u5242\u91cf\uff0c\u7136\u540e\u5c06\u4e3a\u7b2c\u4e8c\u9636\u6bb5\u548c\u968f\u540e\u7684\u5173\u952e\u8bd5\u9a8c\u63d0\u4f9b\u6307\u5bfc\uff0c\u4ee5\u53ca\u6700\u7ec8\u5411FDA\u63d0\u4ea4\u7684\u76d1\u7ba1\u7b56\u7565\u3002<\/p>\n<p>\u201cInhaleRx\u63d0\u524d\u5b8c\u6210\u4e86\u56db\u4e2a\u961f\u5217\u4e2d\u7684\u7b2c\u4e00\u4e2a\uff0c\u8fd9\u5bf9\u516c\u53f8\u6765\u8bf4\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u3002\u6211\u4eec\u6b63\u5728\u5f88\u597d\u5730\u8ddf\u8e2a\u7b5b\u9009\u6211\u4eec\u7684\u4e0b\u4e00\u4e2a\u961f\u5217\uff0c\u6211\u4eec\u671f\u5f85\u8bc4\u4f30IRX211\u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u7279\u5f81\uff0c\u4e3a\u6211\u4eec\u76842\u671f\u7814\u7a76\u63d0\u4f9b\u4fe1\u606f\u3002\u201d<\/p>\n<p>Davies\u5148\u751f\u8bf4\uff0cInhaleRx\u76f8\u4fe1\uff0c\u5438\u5165\u836f\u7269\u5bf9\u75c5\u4eba\u548c\u533b\u751f\u90fd\u6709\u72ec\u7279\u7684\u4f18\u52bf\uff0c\u56e0\u4e3a\u80ba\u90e8\u7684\u5438\u6536\u9762\u79ef\u5f88\u5927\uff0c\u53ef\u4ee5\u5feb\u901f\u5438\u6536\u5230\u8840\u6db2\u4e2d\uff0c\u5e76\u5feb\u901f\u8f93\u9001\u5230\u76ee\u6807\u7ec6\u80de\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u603b\u90e8\u4f4d\u4e8e\u58a8\u5c14\u672c\u7684\u533b\u7597\u4fdd\u5065\u516c\u53f8InhaleRx (ASX: IRX)\u7ee7\u7eed\u786e\u8ba4\u5176\u5438\u5165\u836f\u7269\u75bc\u75db\u836f\u7269\u7cfb\u7edf\u7684\u6f5c\u529b\uff0c\u5b8c\u6210\u4e86\u4e00\u7ec4\u521d\u6b65\u8bd5\u9a8c\u3002 \u8be5\u516c\u53f8\u5df2\u7ecf\u8bc1\u5b9e\uff0c\u5176IRX211\u7cfb\u7edf\u7684\u5b89\u5168\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u7814\u7a76\u5df2\u7ecf\u6210\u529f\u5730\u8fdb\u884c\u4e86\u56db\u7ec4\u961f\u5217\u4e2d\u7684\u7b2c\u4e00\u7ec4i\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002 IRX211\u662f\u4e00\u79cd\u7531\u5927\u9ebb\u7d20\u884d\u751f\u7684\u836f\u7269dronabinol (THC\u4e3a\u57fa\u7840)\uff0c\u901a\u8fc7\u5438\u5165\u4ee5\u56fa\u5b9a\u5242\u91cf\u7ed9\u836f\uff0c\u4ee5\u89e3\u51b3\u7a81\u7834\u6027\u6216\u6025\u6027\u75bc\u75db\u7684\u75c7\u72b6\u3002 \u76ee\u524d\uff0cInhaleRx\u6b63\u5728\u6d4b\u8bd5\u9488\u5bf9\u7a81\u7834\u6027\u75bc\u75db\u6307\u5f81\u76f8\u5173\u75c7\u72b6\u7684\u836f\u7269\u88c5\u7f6e\u7ec4\u5408\u4ea7\u54c1\uff0c\u5305\u62ec\u590d\u6742\u7684\u5c40\u90e8\u75bc\u75db\u7efc\u5408\u5f81\u548c\u5176\u4ed6\u6025\u6027\u75bc\u75db\u6307\u5f81\u3002 \u8be5\u516c\u53f8\u7684\u8bd5\u9a8c\u9879\u76ee\u662f\u9996\u6279\u6d89\u53ca\u5438\u5165\u5927\u9ebb\u7d20\u836f\u7269\u6cbb\u7597\u75bc\u75db\u548c\u7126\u8651\u76f8\u5173\u75be\u75c5\u7684\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u4e00\u3002 \u6570\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a \u6162\u6027\u75bc\u75db\u5e02\u573a\u9884\u8ba1\u5c06\u4ece2023\u5e74\u7684731.4\u4ebf\u7f8e\u5143 (1070\u4ebf\u6fb3\u5143) \u6269\u5927\u52302033\u5e74\u76841425.3\u4ebf\u7f8e\u5143 (2105\u4ebf\u6fb3\u5143)\uff0c\u5728\u9884\u6d4b\u671f\u5185\u4ee56.9%\u7684\u590d\u5408\u5e74\u589e\u957f\u7387 (CAGR) \u589e\u957f\u3002 \u8be5\u516c\u53f8\u5728\u63a8\u52a8\u5176\u72ec\u7279\u4ea7\u54c1\u5546\u4e1a\u5316\u65b9\u9762\u5df2\u7ecf\u53d6\u5f97\u4e86\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0c\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40 (FDA) \u8fdb\u884c\u4e86\u521d\u6b65\u8ba8\u8bba\uff0c\u5e76\u786e\u5b9a\u4e86\u83b7\u5f97\u76d1\u7ba1\u6279\u51c6\u7684\u9014\u5f84\u3002 \u7b2c\u4e00\u961f\u5217\u6218\u5f79 \u7b2c\u4e00\u7ec41\u671f\u8bd5\u9a8c\u7684\u7279\u70b9\u662f\u7ed9\u836f8\u540d\u53c2\u4e0e\u8005\u3002 InhaleRx\u63d0\u524d\u6210\u529f\u5b8c\u6210\u4e86\u961f\u5217\u7814\u7a76\uff0c\u5e76\u5df2\u5f00\u59cb\u7b5b\u9009\u6f5c\u5728\u7684\u7b2c\u4e8c\u961f\u5217\u53c2\u4e0e\u8005\u3002 \u5b8c\u6574\u7684IRX211\u5b89\u5168\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u8bd5\u9a8c\u5c06\u6d89\u53ca4\u4e2a\u961f\u5217\uff0c\u6bcf\u7ec48\u540d\u53c2\u4e0e\u8005\uff0c\u603b\u517132\u540d\u53c2\u4e0e\u8005\uff0c\u4ed6\u4eec\u5c06\u5728\u53cc\u76f2\u3001\u968f\u673a\u3001\u5b89\u6170\u5242\u5bf9\u7167\u3001\u5355\u6b21\u9012\u589e\u5242\u91cf\u7814\u7a76\u4e2d\u63a5\u53d7IRX211\u6216\u5b89\u6170\u5242\u6cbb\u7597\u3002 \u8be5\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98Darryl Davies\u8868\u793a\uff0c\u8fd9\u4e9b\u8bd5\u9a8c\u7684\u7ed3\u679c\u65e8\u5728\u8bc4\u4f30IRX211\u7684\u5355\u6b21\u9012\u589e\u5242\u91cf\uff0c\u7136\u540e\u5c06\u4e3a\u7b2c\u4e8c\u9636\u6bb5\u548c\u968f\u540e\u7684\u5173\u952e\u8bd5\u9a8c\u63d0\u4f9b\u6307\u5bfc\uff0c\u4ee5\u53ca\u6700\u7ec8\u5411FDA\u63d0\u4ea4\u7684\u76d1\u7ba1\u7b56\u7565\u3002 \u201cInhaleRx\u63d0\u524d\u5b8c\u6210\u4e86\u56db\u4e2a\u961f\u5217\u4e2d\u7684\u7b2c\u4e00\u4e2a\uff0c\u8fd9\u5bf9\u516c\u53f8\u6765\u8bf4\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u3002\u6211\u4eec\u6b63\u5728\u5f88\u597d\u5730\u8ddf\u8e2a\u7b5b\u9009\u6211\u4eec\u7684\u4e0b\u4e00\u4e2a\u961f\u5217\uff0c\u6211\u4eec\u671f\u5f85\u8bc4\u4f30IRX211\u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u7279\u5f81\uff0c\u4e3a\u6211\u4eec\u76842\u671f\u7814\u7a76\u63d0\u4f9b\u4fe1\u606f\u3002\u201d Davies\u5148\u751f\u8bf4\uff0cInhaleRx\u76f8\u4fe1\uff0c\u5438\u5165\u836f\u7269\u5bf9\u75c5\u4eba\u548c\u533b\u751f\u90fd\u6709\u72ec\u7279\u7684\u4f18\u52bf\uff0c\u56e0\u4e3a\u80ba\u90e8\u7684\u5438\u6536\u9762\u79ef\u5f88\u5927\uff0c\u53ef\u4ee5\u5feb\u901f\u5438\u6536\u5230\u8840\u6db2\u4e2d\uff0c\u5e76\u5feb\u901f\u8f93\u9001\u5230\u76ee\u6807\u7ec6\u80de\u3002<\/p>\n","protected":false},"author":5,"featured_media":16735,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[1027],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>InhaleRx\u5b8c\u6210\u75bc\u75db\u6cbb\u7597\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"\u603b\u90e8\u4f4d\u4e8e\u58a8\u5c14\u672c\u7684\u533b\u7597\u4fdd\u5065\u516c\u53f8InhaleRx (ASX: IRX)\u7ee7\u7eed\u786e\u8ba4\u5176\u5438\u5165\u836f\u7269\u75bc\u75db\u836f\u7269\u7cfb\u7edf\u7684\u6f5c\u529b\uff0c\u5b8c\u6210\u4e86\u4e00\u7ec4\u521d\u6b65\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InhaleRx\u5b8c\u6210\u75bc\u75db\u6cbb\u7597\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"\u603b\u90e8\u4f4d\u4e8e\u58a8\u5c14\u672c\u7684\u533b\u7597\u4fdd\u5065\u516c\u53f8InhaleRx (ASX: IRX)\u7ee7\u7eed\u786e\u8ba4\u5176\u5438\u5165\u836f\u7269\u75bc\u75db\u836f\u7269\u7cfb\u7edf\u7684\u6f5c\u529b\uff0c\u5b8c\u6210\u4e86\u4e00\u7ec4\u521d\u6b65\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-14T02:20:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/InhaleRx-ASX-IRX-phase-1-clinical-trial-IRX211-pain-management-medication-inhaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/\",\"name\":\"InhaleRx\u5b8c\u6210\u75bc\u75db\u6cbb\u7597\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-06-14T02:20:49+00:00\",\"dateModified\":\"2023-08-29T18:01:22+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u603b\u90e8\u4f4d\u4e8e\u58a8\u5c14\u672c\u7684\u533b\u7597\u4fdd\u5065\u516c\u53f8InhaleRx (ASX: IRX)\u7ee7\u7eed\u786e\u8ba4\u5176\u5438\u5165\u836f\u7269\u75bc\u75db\u836f\u7269\u7cfb\u7edf\u7684\u6f5c\u529b\uff0c\u5b8c\u6210\u4e86\u4e00\u7ec4\u521d\u6b65\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InhaleRx\u5b8c\u6210\u75bc\u75db\u6cbb\u7597\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"InhaleRx\u5b8c\u6210\u75bc\u75db\u6cbb\u7597\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c","description":"\u603b\u90e8\u4f4d\u4e8e\u58a8\u5c14\u672c\u7684\u533b\u7597\u4fdd\u5065\u516c\u53f8InhaleRx (ASX: IRX)\u7ee7\u7eed\u786e\u8ba4\u5176\u5438\u5165\u836f\u7269\u75bc\u75db\u836f\u7269\u7cfb\u7edf\u7684\u6f5c\u529b\uff0c\u5b8c\u6210\u4e86\u4e00\u7ec4\u521d\u6b65\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"InhaleRx\u5b8c\u6210\u75bc\u75db\u6cbb\u7597\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c","og_description":"\u603b\u90e8\u4f4d\u4e8e\u58a8\u5c14\u672c\u7684\u533b\u7597\u4fdd\u5065\u516c\u53f8InhaleRx (ASX: IRX)\u7ee7\u7eed\u786e\u8ba4\u5176\u5438\u5165\u836f\u7269\u75bc\u75db\u836f\u7269\u7cfb\u7edf\u7684\u6f5c\u529b\uff0c\u5b8c\u6210\u4e86\u4e00\u7ec4\u521d\u6b65\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/","og_site_name":"smallcapsCN","article_published_time":"2023-06-14T02:20:49+00:00","article_modified_time":"2023-08-29T18:01:22+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/InhaleRx-ASX-IRX-phase-1-clinical-trial-IRX211-pain-management-medication-inhaled.jpg","type":"image\/jpeg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/","url":"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/","name":"InhaleRx\u5b8c\u6210\u75bc\u75db\u6cbb\u7597\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-06-14T02:20:49+00:00","dateModified":"2023-08-29T18:01:22+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u603b\u90e8\u4f4d\u4e8e\u58a8\u5c14\u672c\u7684\u533b\u7597\u4fdd\u5065\u516c\u53f8InhaleRx (ASX: IRX)\u7ee7\u7eed\u786e\u8ba4\u5176\u5438\u5165\u836f\u7269\u75bc\u75db\u836f\u7269\u7cfb\u7edf\u7684\u6f5c\u529b\uff0c\u5b8c\u6210\u4e86\u4e00\u7ec4\u521d\u6b65\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/inhalerx-completes-first-cohort-phase-1-clinical-trial-pain-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"InhaleRx\u5b8c\u6210\u75bc\u75db\u6cbb\u7597\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6970"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6970"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6970\/revisions"}],"predecessor-version":[{"id":20768,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6970\/revisions\/20768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/16735"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}